Docoh
Loading...

CNMD Conmed

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.

Company profile

Ticker
CNMD
Exchange
Website
CEO
Curt Hartman
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
160977505

CNMD stock data

(
)

Calendar

29 Jul 21
2 Aug 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Conmed earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
30 Jun 21 Daniel Jonas Common Stock Grant Aquire A No No 130.56 15 1.96K 13,821
15 Jun 21 Todd W. Garner Common Stock Sell Dispose S No Yes 137.04 960 131.56K 2,672
11 Jun 21 Schwarzentraub Barbara J Common Stock Sell Dispose S No No 136.903 1,843 252.31K 2,416
11 Jun 21 Schwarzentraub Barbara J Common Stock Option exercise Aquire M No No 73.94 1,843 136.27K 4,259
11 Jun 21 Schwarzentraub Barbara J Options To Purchase Common Stock Common Stock Option exercise Dispose M No No 73.94 1,843 136.27K 0

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 235 246 -4.5%
Opened positions 21 40 -47.5%
Closed positions 32 33 -3.0%
Increased positions 82 94 -12.8%
Reduced positions 96 76 +26.3%
13F shares
Current Prev Q Change
Total value 4.02B 3.45B +16.4%
Total shares 30.78M 30.82M -0.1%
Total puts 110.2K 84.7K +30.1%
Total calls 49.5K 27.8K +78.1%
Total put/call ratio 2.2 3.0 -26.9%
Largest owners
Shares Value Change
BLK Blackrock 4.71M $615.23M +5.2%
Vanguard 3.12M $407.07M +3.8%
Champlain Investment Partners 1.7M $222.65M +0.8%
Earnest Partners 1.64M $213.73M +3.9%
STT State Street 975.61K $127.6M +0.3%
IVZ Invesco 919.47K $120.07M -1.2%
Capital Research Global Investors 832.1K $108.66M +15.8%
Dimensional Fund Advisors 808.25K $105.55M -16.1%
PFG Principal Financial Group Inc - Registered Shares 785.88K $102.63M -14.3%
AMP Ameriprise Financial 755.44K $98.65M +77.5%
Largest transactions
Shares Bought/sold Change
Loomis Sayles & Co L P 645.74K +350.24K +118.5%
Carillon Tower Advisers 0 -334.49K EXIT
AMP Ameriprise Financial 755.44K +329.94K +77.5%
Scopia Capital Management 0 -310.39K EXIT
Norges Bank 0 -271.14K EXIT
Millennium Management 187.59K -244.67K -56.6%
BLK Blackrock 4.71M +233.32K +5.2%
JPM JPMorgan Chase & Co. 386.96K +232.53K +150.6%
HealthCor Management 276.94K +176.94K +176.9%
Dimensional Fund Advisors 808.25K -155.48K -16.1%

Financial report summary

?
Risks
  • Our financial performance is dependent on conditions in the healthcare industry and the broader economy.
  • The COVID-19 global pandemic may pose significant risks to our business if the pandemic, and various government responses to it, continue for an extended period of time.
  • As a manufacturer of medical devices that interacts with physicians and health care providers domestically and internationally, we face risks under domestic and foreign regulations, including the Foreign Corrupt Practices Act.
  • The highly competitive market for our products may create adverse pricing pressures.
  • Cost reduction efforts in the healthcare industry could put pressures on our prices and margins.
  • We may not be able to keep pace with technological change or to successfully develop new products with wide market acceptance, which could cause us to lose business to competitors.
  • Our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly.
  • Our interest rates may be impacted by the phase out of LIBOR.
  • The convertible notes hedge and warrant transactions that we entered into in connection with the offering of the Convertible Notes may affect the value of the Convertible Notes and our common stock.
  • We are subject to counterparty risk with respect to the convertible notes hedge transactions.
  • The terms of any future preferred equity or debt financing may give holders of any preferred securities or debt securities rights that are senior to rights of our common shareholders or impose more stringent operating restrictions on our company.
  • We could experience a failure of a key information technology system, process or site or a breach of information security, including a cybersecurity breach or failure of one or more key information technology systems, networks, processes, associated sites or service providers, and could potentially become liable for a breach of various data privacy regulations.
  • We rely on a third party to obtain, process and distribute sports medicine allograft tissue. If such tissue cannot be obtained, is not accepted by the market or is not accepted under numerous government regulations, our results of operations could be negatively impacted.
  • We distribute some products for third-party companies, and cannot ensure that our rights to distribute such third-party products will continue indefinitely.
  • If we lose our patents or they are held to be invalid, or if our products or services infringe on third party patents, we could become subject to liability and our competitive position could be harmed.
  • Damage to our physical properties as a result of windstorm, earthquake, fire or other natural or man-made disaster may cause a financial loss and a loss of customers.
  • Our new products may fail to achieve expected levels of market acceptance.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: alternate, anniversary, carrier, chemical, closing, defense, discovery, ease, endoscopic, greatest, iii, indemnification, indemnifying, influence, injury, landlord, Prime, purportedly, range, today, variability, waiting
Removed: annum, cancelled, certainty, commitment, depend, fee, long, offsetting, positioned, put, rapidly, residual, return, show, subsided, travel, uncertain, vision

Patents

GRANT
Utility
Length adjustable cannula
27 Jul 21
A length adjustable cannula includes: a pipe-like main body having a through hole formed therein and an outer circumferential surface on which a screw thread is formed; a base grip provided at an end of the main body; an inner support plate provided at another end of the main body; and an outer support plate thread-coupled with the outer circumferential surface of the main body, the outer support plate being movable along the screw thread in a lengthwise direction of the main body.
GRANT
Utility
Multi-modal surgical gas circulation system for controlling a network of gas sealed access devices
20 Jul 21
A system for performing an endoscopic surgical procedure in a surgical cavity is disclosed which includes a primary gas circulation device housing a central processor and a primary pump, the primary pump controlled by the central processor and configured to deliver a flow of pressurized gas to a primary gas delivery lumen and to receive gas from a primary gas return lumen, and a plurality of subordinate gas circulation devices each housing a respective subordinate pump configured to deliver a flow of pressurized gas to a respective subordinate gas delivery lumen and to receive gas from a respective subordinate gas return lumen, wherein the subordinate pump in each subordinate gas circulation device is in networked communication with and controlled by the central processor of the primary gas circulation device.
APP
Utility
Separate Printed Traces for Ecg and Defibrillation Circuits
1 Jul 21
An electrode pad with a defibrillation circuit and a separate ECG tracing circuit.
APP
Utility
Uterine Manipulator
1 Jul 21
A uterine manipulator device includes: an elongated cannulated tube comprising a proximal end and a distal end; a cervical cup having a top proximal portion of a first diameter and a base distal portion of a second smaller diameter, wherein: the base distal portion includes a hole formed therein having a perimeter including a distal end and a proximal end, and including a longitudinal axis positioned therethrough; one of the proximal end of the perimeter and the distal end of the perimeter is angled away from the longitudinal axis and the other of the proximal end of the perimeter and the distal end of the perimeter is in line with the longitudinal axis; and the elongated cannulated tube is positioned through the hole in the cervical cup.
APP
Utility
Easy Start Cannulated Bone Screw
1 Jul 21
A surgical screw for fixation into bone or soft tissue.